Tangfeng Lv

机构：Nanjing General Hospital of Nanjing Military Command, Nanjing Medical University, Nanjing University · ORCID：0000-0001-7224-8468

发表论文 356 篇 · 总被引 8647 次 · h-index 48

代表论文

• Intrapleural dual blockade of IL-6 and PD-L1 reprograms CAF dynamics and the tumor microenvironment in lung cancer-associated malignant pleural effusion (2025 · Respiratory Research · 被引 15)
• First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial (2025 · The Lancet Respiratory Medicine · 被引 7)
• Molecular subtyping dictates therapeutic response to anti-PD-L1 immunotherapy in ES-SCLC (2025 · Cancer Immunology Immunotherapy · 被引 6)
• Tumor immune microenvironment analysis in different pathologic responses to neoadjuvant immunotherapy combined with chemotherapy in non-small cell lung cancer (2025 · Translational Lung Cancer Research · 被引 5)
• International guidelines on the diagnosis and treatment of NUT carcinoma (2025 · The Innovation · 被引 5)
• Multi-marker GWAS and variant-specific genomic prediction for growth traits in Pacific white shrimp (2025 · Scientific Reports · 被引 3)